MPP dihydrochloride hydrate
SIGMA/M7068 - ≥97% (HPLC), white, powder
Synonym: 1,3-
CAS Number: 911295-24-4 (anhydrous)
Empirical Formula (Hill Notation): C29H31N3O3 · 2 HCl · xH2O
Molecular Weight: 542.50 (anhydrous basis)
MDL Number: MFCD06411603
Linear Formula: C29H31N3O3 · 2 HCl · xH2O
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C29H31N3O3.2ClH/c1-21- |
| InChI key | FWDNPWVVRVSJQH-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.Cl.Cc1c(nn(-c2ccc(O)cc |
| solubility | DMSO: soluble ≥20 mg/mL |
| storage condition | desiccated |
| Application: | MPP dihydrochloride hydrate has been used as an estrogen receptor α antagonist: • in human breast cancer MCF-7 cells • to pre-treat endometrial ex vivo organ cultures (EVOCs) • to treat pituitary glands to monitor luteinizing hormone secretion |
| Biochem/physiol Actions: | Methyl-piperidino-pyrazol |
| Biochem/physiol Actions: | MPP dihydrochloride is a specific estrogen receptor α antagonist. |
| Biochem/physiol Actions: | Specific estrogen receptor α antagonist. |
| General description: | Methyl-piperidino-pyrazol |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research ![]() |
| Packaging: | 10, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| UNSPSC | 51111800 |

